Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1298402A reveals a safer synthesis route for anti-arrhythmic agents, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115703796A reveals a high-yield route for Remdesivir intermediates using methylthio-substitution, offering significant cost reduction and supply chain stability for API manufacturing.
Patent CN115626947B reveals a novel Tempo-NaClO-KBr oxidation route for pentacyclic triterpenes. Achieve significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel serine-based route for methyl 2,3-diaminopropionate. Mild conditions, high yield, scalable process for peptidomimetic inhibitor manufacturing.
Novel serine-based route for methyl 2,3-diaminopropionate offers cost reduction and mild conditions for peptide inhibitor manufacturing.
Patent CN101370759B details a high-yield reduction of halogenated terephthalic acids. This process offers significant cost reduction in pharmaceutical intermediates manufacturing through optimized acid workup.
Novel 10-step synthesis for Lobeline avoiding expensive catalysts. High yield, mild conditions. Reliable pharmaceutical intermediate supplier for global markets.
Patent CN107474001B details a copper-catalyzed oxidative ring contraction method. Offers cost-effective routes for high-purity pharmaceutical intermediates with simplified supply chains.
Novel acetylation-bromination-hydrolysis route offers high yield and mild conditions for reliable pharmaceutical intermediate supply chains.
Novel elimination method for high-purity 16-dehydroprogesterone. Cost-effective, scalable process for steroid drug manufacturing utilizing biphasic catalysis.
Patent CN108137530A details optical resolution for β-2-thienyl-alanine. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN101100428B details an eco-friendly boric acid catalyzed route for high-purity chiral diethyl tartrate, offering significant cost and environmental advantages for pharma supply chains.
Novel patent CN112724189B details waste-to-value synthesis enhancing supply chain reliability and cost efficiency for global pharmaceutical intermediate procurement strategies.
Patent CN109824539B details a novel 6-step Tigecycline synthesis from Demethyl Aureomycin, offering high purity, cost reduction, and scalable manufacturing for pharmaceutical intermediates.
Patent CN101180263B reveals a novel 3-step synthesis eliminating dimer impurities. Discover cost-effective manufacturing and stable salt forms for neurodegenerative disease therapeutics.
Discover a novel palladium-catalyzed method for synthesizing chiral indole-2,3-fused eight-membered rings. Efficient, scalable route for high-purity pharmaceutical intermediates.
Patent CN1752086A reveals a mild, one-pot synthesis for Azelnidipine intermediates, offering high purity and cost reduction in calcium channel blocker manufacturing.
Novel patent CN110078651A offers green synthesis for 3,3'-bipyrrole intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN1469864A details improved alkylation methods using phase transfer or buffered inorganic bases, enhancing yield and reducing costs for pharmaceutical intermediates.
Novel route for Gefitinib avoiding methanesulfonic acid demethylation, offering cost-effective API intermediate manufacturing solutions.